Cancer Diagnostics: A Market on the Verge of Explosion--Supplier Shares and Market Segment Forecasts by Tests--Technological Breakthroughs, Emerging Tests, Competitive Intelligence

Wednesday, June 27, 2018 Cancer News
Email Print This Page Comment bookmark
Font : A-A+

LONDON, June 27, 2018 /PRNewswire/ -- The report is a study of the major business opportunities emerging in the global cancer

diagnostics market during the next five years. The report examines trends in the U.S., Europe and Japan; reviews current and emerging assays; analyzes potential applications of new diagnostic
technologies; forecasts sales of major tumor markers by country and market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers.

Download the full report: https://www.reportbuyer.com/product/5446290

Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.

Geographic Coverage

France, Germany, Italy, Japan, Spain, UK, USA

Worldwide Market Overview

- Five-year test volume and sales projections by country.

- Comprehensive market segmentation analysis, including reviewof the market dynamics, structure, size, growth and major suppliers by country.

- Estimated universe of laboratories performing cancer diagnostic testing by country.

- Cancer statistics, etiology and recent developments in the U.S., Europe, and Japan.

Business Opportunities and Strategic Recommendations

- Specific new product development opportunities with potentiallysignificant market appeal during the next five years.

- Design criteria for new products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Over 200 Current and Emerging Cancer Diagnostic Test

- Biochemical Markers- Oncogenes- Growth Factors- Hormones- Colony Stimulating Factors- Lymphokines- Immunohistochemical Stains, and others.

- ACTH, AFP, Beta-2 Microglobulin, CA 15-3/27.29, CA 19-9, CA 125, Calcitonin, Cathepsin, CEA,Chromogranin, Colon-Specific Antigen, Cytokeratins, Estrogen Receptor, Ferritin, Gastrin, HCG,Insulin, Interferons, Interleukins, Lymphocyte Subtyping, Neuron-Specific Enolase, Nucleolar,Occult Blood, Oncogenes, Pancreatic Oncofetal Antigen, Pap Smear, Parathyroid Hormone,Progesterone Receptor, Prostatic Acid Phosphatase, Prostatic Specific Antigen, S-100 Protein,Serotonin, Sialic Acid, Squamous Cell Carcinoma Ag, TDT, Thymidine Kinase, Thyroglobulin,Tissue Polypeptide Antigen, and others.

Supplier Shares, Sales and Volume Forecasts

- Sales and market shares of major cancer diagnostic productsuppliers by individual test and country.

- Five-year test volume and sales forecastsfor major tumor markers by country and market segment, including:

- Hospitals- Commercial/Private Laboratories- Physician Offices/Group Practices- Cancer Clinics- Ambulatory Care Centers

Instrumentation Review

- Analysis of major molecular diagnostic and immunodiagnostic analyzersused for cancer testing, including their operating characteristics,features and selling prices.

Technology Assessment

- Assessment of latest molecular diagnostic methods,biochips/microarrays, biosensors, monoclonal antibodies, immunoassays,chromosome analysis, IT, artificial intelligence, flow cytometry, and other technologiesand their potential applications for cancer diagnostic testing.

- Review of competing/complementing technologies, includingCT, MRI, NMR, PET and photonics spectroscopy.

- Extensive listings of companies, universitiesand research centers developing new cancer diagnostic testsand detection technologies.

Competitive Strategies

- Strategic assessments of major suppliersand start-up firms developing innovativetechnologies and products, including their sales,product portfolios, marketing tactics, collaborativearrangements, and new products in RandD.

- The companies analyzed in the report include:

   - Abbott   - AdnaGen   - Agilent Technologies   - Applied Gene Technologies   - Arca Biopharma   - Beckman Coulter/Danaher   - Becton Dickinson   - Biomedical Diagnostics   - bioMerieux   - Bio-Rad   - CellSearch   - Cepheid   - Correlogic Systems/Vermillion   - Decode Genetics   - Diadexus   - Diagnocure   - DiaSorin   - Eiken Chemical   - Elitech Group   - Enterix   - Enzo Biochem   - Epigenomics   - Fujirebio   - Guided Therapeutics   - Hologic/Gen-Probe   - Kreatech/Leica   - Kyowa Medex   - Mackay Life Sciences   - Myriad Genetics   - OncoLab   - Ortho-Clinical Diagnostics   - Panacea Pharmaceuticals   - Polartechnics   - Polymedco   - PreMD   - Qiagen   - Quest Diagnostics   - Radient Pharmaceuticals   - Roche   - Scienion   - Sequenom   - Siemens Healthcare   - Takara Bio   - Targeted Diagnostics and Therapeutics   - Thermo Fisher   - Tosoh   - Veridex   - Wako Pure Chemicals   - Wallac/PE   - Zilla

Contains 1,200 pages and 450 tables

Download the full report: https://www.reportbuyer.com/product/5446290 About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: sarah@reportbuyer.com Tel: +1 (718) 213 4904 Website: www.reportbuyer.com

Cision View original content:http://www.prnewswire.com/news-releases/cancer-diagnostics-a-market-on-the-verge-of-explosion--supplier-shares-and-market-segment-forecasts-by-tests--technological-breakthroughs-emerging-tests-competitive-intelligence-300673389.html

SOURCE ReportBuyer



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store